Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
5.48
-0.04 (-0.64%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Decoy Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
2.91M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GeoVax Labs | 2.49M |
| Scinai Immunotherapeutics | 1.31M |
| HCW Biologics | 54.23K |
| Azitra | 7.50K |
| Virax Biolabs Group | 2.99K |
DCOY News
- 1 day ago - Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston - PRNewsWire
- 19 days ago - Decoy Therapeutics Transcript: Status update - Transcripts
- 19 days ago - Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline - PRNewsWire
- 22 days ago - Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026 - PRNewsWire
- 26 days ago - Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 6 weeks ago - Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform - PRNewsWire
- 7 weeks ago - Decoy Therapeutics Announces 1-for-12 Reverse Stock Split - PRNewsWire
- 2 months ago - Decoy Therapeutics Joins Webull Corporate Connect Service Platform - PRNewsWire